Cystatin SN can strongly predict chronic rhinosinusitis with nasal polyps: Study
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2021-04-03 03:30 GMT | Update On 2021-04-03 08:13 GMT
Advertisement
China: Cystatin SN can help in the management of patients with chronic rhinosinusitis with nasal polyps (CRSwNP), finds a recent study in the Journal of Allergy and Clinical Immunology. According to the study, the levels of cystatin SN in nasal secretion have strong prognostic value and can aid medical guidance on CRSwNP.
Integrated care pathways (ICPs) can improve the management of CRSwNP patients. ICPs application requires development of endotype-based biomarkers to stratify patients. The value of markers and cytokines induced by cytokines for CRSwNP management is largely unknown.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.